Similarly, PTEN underexpression was observed in 40% of triple-negative tumors versus 13% in other breast cancer subtypes, suggesting different mechanisms underlining PI3K pathway deregulation in specific breast tumor subtypes. The gene discussed is PTEN; the disease is breast carcinoma.